NCT03067675 is a clinical trial of Topcon DRI OCT Triton (plus) in Healthy Eyes, sponsored by Topcon Corporation.

Who is sponsoring NCT03067675?

NCT03067675 is sponsored by Topcon Corporation.

What drugs are being tested in NCT03067675?

Interventions in NCT03067675: Topcon DRI OCT Triton (plus).

What condition does NCT03067675 study?

NCT03067675 studies Healthy Eyes.

Is NCT03067675 still recruiting?

NCT03067675 is currently completed. Last updated 8 June 2022.

Last reviewed 2022-06-08 · How we verify

NCT03067675

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Triton Reference Database

Completed Last updated 8 June 2022

What this trial tests

trial testing Topcon DRI OCT Triton (plus) in Healthy Eyes in 500 participants. Completed in 30 September 2017.

Timeline

1 March 2017

Primary endpoint
30 August 2017

30 September 2017

Quick facts

Lead sponsor	Topcon Corporation
Status	Completed
Study type	OBSERVATIONAL
Enrollment	500
Start date	1 March 2017
Primary completion	30 August 2017
Estimated completion	30 September 2017
Sites	6 locations across United States

Drugs / interventions tested

Topcon DRI OCT Triton (plus)

Conditions studied

Healthy Eyes — all drugs for Healthy Eyes →

Sponsor

Topcon Corporation

Who can join

18 and older, any sex, with Healthy Eyes. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The objective of this study is to collect OCT measurement data on normal healthy eyes.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Topcon DRI OCT Triton (plus)

Trials testing the same drug.

NCT03107104 — Triton Fundus Autofluorescence and Fluorescein Angiography · completed
NCT03080714 — Triton Agreement and Precision Study · completed

Other recruiting trials for Healthy Eyes

Currently open trials in the same condition.

NCT06991127 — Clinical Investigation of MAIA Microperimeter Device: Mesopic Normative Database Collection · NA · recruiting

Other Topcon Corporation trials

Trials by the same sponsor.

NCT06733428 — Agreement and Precision Study · completed
NCT06250868 — TRK-3 Performance of Pachymetry · completed
NCT06247072 — TRK-3 Conformance to Standards for Tonometers · completed
NCT06135727 — Screening Protocol · terminated
NCT05286502 — NW500 Non-Mydriatic Retinal Camera Clinical Performance Study · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03067675 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Topcon Corporation
Last refreshed: 8 June 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03067675.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing